CA2744448A1 - Polymorphs - Google Patents

Polymorphs Download PDF

Info

Publication number
CA2744448A1
CA2744448A1 CA2744448A CA2744448A CA2744448A1 CA 2744448 A1 CA2744448 A1 CA 2744448A1 CA 2744448 A CA2744448 A CA 2744448A CA 2744448 A CA2744448 A CA 2744448A CA 2744448 A1 CA2744448 A1 CA 2744448A1
Authority
CA
Canada
Prior art keywords
vorinostat
crystalline
process according
mixture
vorinostat form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2744448A
Other languages
English (en)
French (fr)
Inventor
Vinayak Gore
Madhukar Patil
Rahul Bhalerao
Hemant Mande
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Generics UK Ltd
Original Assignee
Generics UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Generics UK Ltd filed Critical Generics UK Ltd
Publication of CA2744448A1 publication Critical patent/CA2744448A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA2744448A 2008-11-26 2009-11-25 Polymorphs Abandoned CA2744448A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2057KO2008 2008-11-26
IN2057/KOL/2008 2008-11-26
PCT/GB2009/051596 WO2010061219A2 (en) 2008-11-26 2009-11-25 Polymorphs

Publications (1)

Publication Number Publication Date
CA2744448A1 true CA2744448A1 (en) 2010-06-03

Family

ID=42226168

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2744448A Abandoned CA2744448A1 (en) 2008-11-26 2009-11-25 Polymorphs

Country Status (8)

Country Link
US (1) US8754129B2 (enExample)
EP (1) EP2362869A2 (enExample)
JP (1) JP2012509929A (enExample)
CN (1) CN102282126A (enExample)
AU (1) AU2009321384A1 (enExample)
CA (1) CA2744448A1 (enExample)
NZ (1) NZ593585A (enExample)
WO (1) WO2010061219A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2349985A2 (en) 2008-10-15 2011-08-03 Generics [UK] Limited Process for the preparation of vorinostat
CN110283102B (zh) * 2019-05-31 2022-09-27 宿州亿帆药业有限公司 一种伏林司他ⅰ晶型的制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5369108A (en) 1991-10-04 1994-11-29 Sloan-Kettering Institute For Cancer Research Potent inducers of terminal differentiation and methods of use thereof
GB9504084D0 (en) 1995-03-01 1995-04-19 British Biotech Pharm Synthesis of carboxylic and hydroxamic acid derivatives
IT1283637B1 (it) 1996-05-14 1998-04-23 Italfarmaco Spa Composti ad attivita' antinfiammatoria ed immunosoppressiva
US6497820B1 (en) 1998-02-03 2002-12-24 Arqule, Inc. Rapid method for separation of small molecules using reverse phase high performance liquid chromatography
CA2391952C (en) 1999-11-23 2012-01-31 Methylgene Inc. Inhibitors of histone deacetylase
US7456219B2 (en) 2002-03-04 2008-11-25 Merck Hdac Research, Llc Polymorphs of suberoylanilide hydroxamic acid
NZ550185A (en) 2002-03-04 2008-10-31 Merck Hdac Res Llc Methods of inducing terminal differentiation Methods of inducing terminal differentiation
EP1663194B1 (en) 2003-08-26 2010-03-31 Merck HDAC Research, LLC Use of SAHA for treating mesothelioma
EP1541549A1 (en) 2003-12-12 2005-06-15 Exonhit Therapeutics S.A. Tricyclic hydroxamate and benzaminde derivatives, compositions and methods
UA93355C2 (ru) * 2005-05-20 2011-02-10 Mepk Шарп Энд Доме Корп. Композиция субероиланилид-гидроксаминовой кислоты и способы ee получения
TWI415603B (zh) 2005-05-20 2013-11-21 Merck Sharp & Dohme １，８－辛二醯基苯胺羥胺酸（ｓｕｂｅｒｏｙｌａｎｉｌｉｄｅ ｈｙｄｒｏｘａｍｉｃ ａｃｉｄ）之調配物及其製配方法
CA2663569A1 (en) * 2006-09-28 2008-04-03 Merck & Co., Inc. Pharmaceutical compositions of hdac inhibitors and chelatable metal compounds, and metal-hdac inhibitor chelate complexes
CA2663614A1 (en) 2006-09-28 2008-04-10 Merck And Co., Inc. Amine base salts of saha and polymorphs thereof
AU2008337304A1 (en) 2007-12-14 2009-06-25 Generics [Uk] Limited HPLC method for analysing clopidogrel
JP2011511053A (ja) 2008-02-07 2011-04-07 ジェネリクス・（ユーケー）・リミテッド ボリノスタットの新規な製造方法
US20090223286A1 (en) 2008-02-13 2009-09-10 Vandana Singh Analytical method for determination of related substances of imipenem and cilastatin
CZ2008167A3 (cs) 2008-03-14 2010-02-24 Zentiva, A. S. Specifické necistoty montelukastu
EP2349985A2 (en) 2008-10-15 2011-08-03 Generics [UK] Limited Process for the preparation of vorinostat
CA2744458A1 (en) 2008-11-26 2010-06-03 Generics [Uk] Limited Novel processes and pure polymorphs
WO2011061545A1 (en) 2009-11-23 2011-05-26 Generics [Uk] Limited Hplc method for analyzing vorinostat

Also Published As

Publication number Publication date
JP2012509929A (ja) 2012-04-26
NZ593585A (en) 2012-12-21
US8754129B2 (en) 2014-06-17
US20110263713A1 (en) 2011-10-27
CN102282126A (zh) 2011-12-14
WO2010061219A2 (en) 2010-06-03
EP2362869A2 (en) 2011-09-07
WO2010061219A3 (en) 2010-08-12
AU2009321384A1 (en) 2011-06-23

Similar Documents

Publication Publication Date Title
CA2988393C (en) Solid state forms of sofosbuvir
US9309201B2 (en) Process for preparating ivabradine hydrochloride form IV and methods of treatment of disease using ivabradine hydrochloride form IV
KR20080064978A (ko) 라퀴니모드 나트륨의 결정 및 이의 제조방법
CN1812968B (zh) 4-[6-乙酰基-3-[3-(4-乙酰基-3-羟基-2-丙基苯硫基)丙基]-2-丙基苯氧基]丁酸的多晶型物
US20110269838A1 (en) Novel processes and pure polymorphs
JP6957807B2 (ja) 右旋性オキシラセタムの２型結晶、調製方法および用途
EP3569590A1 (en) (r)-4-hydroxy-2-oxo-1-pyrrolidineacetamide crystal form, preparation method therefor, and application thereof
JPH0526782B2 (enExample)
US8754129B2 (en) Crystalline vorinostat form VI
JP2007526229A (ja) ４−［６−アセチル−３−［３−（４−アセチル−３−ヒドロキシ−２−プロピルフェニルチオ）プロポキシ］−２−プロピルフェノキシ］酪酸の多形形態ａの製造方法
CN106478616B (zh) 一种gpr40激动剂的结晶形式及其制备方法
US20190152918A1 (en) Crystalline calcium salt of (s)-2-(diphenylacetyl)-1,2,3,4-tetrahydro-6-methoxy-5-(phenylmethoxy)-3-isoquinoline carboxylic acid
CA3191776A1 (en) Salts of fenfluramine
CN102219752A (zh) 一种1-(2,6-二氟苄基)-1h-1,2,3-三唑-4-甲酰胺的新晶型d

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20150710